This inventor holds 5 USPTO granted patents. Top assignees: Glaxo Group Limited, Glaxo Wellcome Inc., Smithkline Beecham Corporation. Active years: 1994-2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Greenford, GB (1994 - 1995)
- Stevenage, GB (2000)
- Mitchin, GB (2002)
Company Filing History:


Years Active: 1994-2002
Title: Michael John Dawson: Innovator in Enantiomerically Enriched Compounds
Introduction
Michael John Dawson is a notable inventor based in Stevenage, GB. He has made significant contributions to the field of chemistry, particularly in the preparation of enantiomerically enriched compounds. With a total of 5 patents to his name, Dawson's work has had a considerable impact on various applications in the pharmaceutical industry.
Latest Patents
Dawson's latest patents include a process for preparing enantiomerically enriched N-derivatized lactams. This invention relates to a method for the preparation of enantiomerically enriched N-derivatized (1R,4S)-2-azabicyclo[2.2.1]hept-5-en-3-ones using an enzyme. Another significant patent is for the preparation of N-acetylneuraminic acid, which describes a method for producing N-acetyl-D-neuraminic acid (NANA) from N-acetyl-D-glucosamine (NAG).
Career Highlights
Throughout his career, Dawson has worked with prominent companies in the pharmaceutical sector, including Glaxo Group Limited and SmithKline Beecham Corporation. His expertise in the field has allowed him to develop innovative processes that enhance the efficiency and effectiveness of drug development.
Collaborations
Dawson has collaborated with several notable individuals in his field, including David Noble and Michael V Hayes. These collaborations have contributed to the advancement of his research and the successful development of his patented processes.
Conclusion
Michael John Dawson is a distinguished inventor whose work in the preparation of enantiomerically enriched compounds has made a lasting impact on the pharmaceutical industry. His contributions continue to influence the field and inspire future innovations.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile